Clinical Trials on General Health Education in Australia

Total 9476 results

Amckaus PTY LTD.

Recruiting

Aom0319 SAD Study in Healthy Subjects

Healthy Volunteers

Australia
Inmagene LLC

Active, not recruiting

Safety and Pharmacokinetics of Subcutaneous Dose of IMG-007 in Healthy Participants

Healthy Volunteers

Australia
RANI Therapeutics

Completed

Study Evaluating PK of Ustekinumab Administered Orally Via RaniPill™ Capsule

Healthy Volunteers

Australia
Foresee Pharmaceuticals Co., Ltd.

Completed

Multiple-Dose, Dose-Escalation Study to Evaluate the Safety/Tolerability and Pharmacokinetics of FP-045

Healthy Volunteers

Australia
Chengdu SciMount Pharmatech Co., Ltd.

Completed

3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability

Healthy Volunteers

Australia
SIMR (Australia) Biotech Pty Ltd.
Syneos Health

Completed

The Safety, Tolerability, Pharmacokinetics(PK) of SR419 in Healthy Volunteers

Healthy Volunteers

Australia
RANI Therapeutics

Completed

A First-in-Human Study of the RaniPill, an Oral Drug Delivery Platform (RaniPill)

Healthy Volunteers

Australia
Prestige Biopharma Limited

Completed

A Study to Demonstrate the Equivalent Pharmacokinetic Properties of a Single Intravenous Dose of HD201 and EU-Herceptin® and US-Herceptin® in Healthy Male Subjects (TROIKA-1)

Healthy Volunteers

Australia
RANI Therapeutics

Completed

Study Evaluating PK of PTH Administered Orally Via RaniPill™ Capsule

Healthy Volunteers

Australia
Principia Biopharma, a Sanofi Company

Completed

Food Effect and Relative Bioavailability Study of Rilzabrutinib in Healthy Participants

Healthy Volunteers

Australia
Chengdu SciMount Pharmatech Co., Ltd.

Completed

A Phase 1 Study of SMP-100 in Normal Healthy Volunteers

Healthy Volunteers

Australia
Protagonist Therapeutics, Inc.

Completed

Pharmacokinetics of PN-235 in Healthy Volunteers

Healthy Volunteers

Australia
Angion Biomedica Corp

Completed

ANG-3070 in Healthy Adult Participants

Healthy Volunteers

Australia
Galera Therapeutics, Inc.

Completed

A Phase 1 Study of the Safety and Pharmacokinetics of GC4711 (Oral Capsule) Compared to GC4419 (IV Infusion) and GC4711 (IV Infusion) in Healthy Volunteers

Healthy Volunteers

Australia
Regeneron Pharmaceuticals

Completed

Intravenous/Subcutaneous FIH Study of REGN1154 in Healthy Volunteers

Healthy Volunteers

Australia
National Institutes of Health Clinical Center (CC)

Completed

Dietary Linoleic Acid for Secondary Prevention of Coronary Heart Disease and Death in the Sydney Heart Study: an RCT

Coronary Heart Disease

Australia
Flinders University
Flinders Medical Centre; Lyell McEwin Hospital

Recruiting

Assessment of Myocardial Injury in Patients Treated With Immune Checkpoint Inhibitors (MIICI)

Myocardial Injury | Myocarditis | Cardiotoxicity | Immune Checkpoint Inhibitors

Australia
VDyne, Inc.

Recruiting

Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation (VISTA)

Tricuspid Regurgitation | Tricuspid Valve Disease | Tricuspid Valvular Disorders

Australia, Czechia, Austria
Medical University of Graz

Recruiting

Austrian Wearable Cardioverter Defibrillator Registry

Heart Failure | Ventricular Fibrillation | Ventricular Tachycardia | Ventricular Dysfunction | Sudden Death | Sudden Cardiac Arrest

Austria
Royal Perth Hospital
The University of Western Australia

Recruiting

Sympathoinhibition as a Preferred Second Line Treatment of Obesity Related Hypertension (OHT)

Hypertension | Obesity

Australia
Medical University of Graz

Completed

Patient Perceptions and Physician Assessment of Benefits and Risks of Oral Anticoagulation Due to Non-valvular AF

Atrial Fibrillation | Health Literacy

Austria
Bayside Health
The Alfred

Unknown

BNP Testing in Patients With SOB on Presentation to ED

Heart Failure, Congestive

Australia
Pharmosa Biopharm Inc.
Novotech (Australia) Pty Limited

Recruiting

Safety, Tolerability and Pharmacokinetics of L608 in Healthy Adults

Pulmonary Arterial Hypertension

Australia
Biotronik Australia Pty Ltd.
Biotronik SE & Co. KG

Active, not recruiting

BIO|CONCEPT.Amvia Study

Heart Failure | Bradycardia

Australia
University of South Australia
American Egg Board

Completed

Independent Effects of High-cholesterol (High-egg) and High-saturated Fat Diets on LDL-cholesterol

Hypercholesterolemia | Hyperlipidemias | Diet, Healthy | Physical Inactivity

Australia
Eli Lilly and Company

Completed

New Oral Anticoagulant Therapy for the Prevention of Blood Clots Following Hip or Knee Replacement Surgery

Total Hip Replacement | Total Knee Replacement

Australia, Austria, Belgium, Czech Republic, Germany, Hungary, Italy, Poland
Curtin University

Completed

The Fall Monty Activity Programme Feasibility Study (FallMAP)

Stroke

Australia
Flinders University
The Queen Elizabeth Hospital; Flinders Medical Centre; Royal Adelaide Hospital

Completed

Effect of Exercise Training on Protein Expression in Skeletal Muscle Tissue After Exercise in Peripheral Arterial Disease

Peripheral Arterial Disease

Australia
Turgut Ardika PTY LTD

Recruiting

Comparative PK, Safety, Tolerability, Immunogenicity, and PD Profile Study of TUR03 and Soliris in Healthy Participants

Healthy

Australia
Circadian Therapeutics Ltd
Neuroscience Trials Australia

Completed

First in Human Study of CT-1500 in Healthy Participants

Healthy

Australia
Arrowhead Pharmaceuticals

Completed

A Study of ARC-520 at Varying Infusion Rates in Healthy Adult Volunteers

Healthy

Australia
Monash University
National Health and Medical Research Council, Australia; Cerebral Palsy Alliance and other collaborators

Recruiting

Antenatal Melatonin Supplementation for Neuroprotection in Fetal Growth Restriction (PROTECTMe)

Fetal Growth Retardation | Pregnancy Preterm | Stillbirth and Fetal Death

Australia, New Zealand
Australian and New Zealand Intensive Care Research...

Active, not recruiting

Blend to Limit Oxygen in ECMO: A Randomised Controlled Registry Trial (BLENDER)

Critical Illness | Cardiac Failure

Australia
Australian and New Zealand Intensive Care Research...

Active, not recruiting

Blender Biomarkers: A BLENDER Sub-study to Evaluate the Effect of Oxygen Dose on Oxidative Stress and Organ Injury

Critical Illness | Cardiac Failure

Australia
Tyra Biosciences, Inc

Recruiting

A Relative Bioavailability and Food Effect Study of TYRA-300-B01 Capsule and Tablet Formulations in Healthy Adult Participants

Healthy

Australia
BeiGene

Completed

BGB-DXP604 Alone and in Combination With BGB-DXP593 in Healthy Participants

Healthy

Australia
MyoKardia, Inc.

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Oral Doses of MYK-461 in Healthy Volunteers

Healthy

Australia
Elixiron Immunotherapeutics Inc.

Recruiting

First in Human Study of EI-001 Monoclonal Antibody in Healthy Volunteers

Healthy

Australia
Alexion Pharmaceuticals, Inc.

Completed

Bioavailability Study of 2 Oral Formulations of ALXN1840

Healthy

Australia
Karyopharm Therapeutics Inc

Terminated

Trial of Safety and Tolerability of Oral Verdinexor (KPT-335) in Healthy Adults

Healthy

Australia
Pulmatrix Inc.

Completed

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of PUR3100 in Health Adults

Healthy

Australia
Galera Therapeutics, Inc.

Completed

A Study Designed to Evaluate the Safety and Pharmacokinetics of Intravenously Administered Superoxide Dismutase Mimetic GC4711 in Healthy Volunteers

Healthy

Australia
Emerald Health Pharmaceuticals

Completed

To Evaluate the Safety and Tolerability, Pharmacokinetics, Food-effect and Pharmacodynamics of EHP-101 in Healthy Volunteers

Healthy

Australia
Arrowhead Pharmaceuticals

Completed

Safety and Tolerability Study of ARC-520 in Healthy Volunteers

Healthy

Australia
CSL Limited

Completed

A Multiple Ascending Dose Study of CSL112 in Healthy Volunteers

Healthy

Australia
Kirby Institute

Not yet recruiting

The National Australian HCV Point-of-Care Testing Program - HCV Antibody Testing Minimal Dataset

Hepatitis C

Australia
Advanced NanoTherapies
Monash University; Cardiovascular Research Foundation, New York; Cogent Technologies...

Recruiting

ADVANCEd NanoTherapies Dual Active Pharmacological Ingredient (Dual-API) Drug-Coated Balloon to Treat De-Novo Lesions in Patients With Symptomatic Stable Coronary Artery Disease (ADVANCE-DCB)

Coronary Artery Disease

Australia
Monash University
Curtin University; Flinders University; Ambulance Victoria; SA Ambulance Service

Completed

rEduction of oXygen After Cardiac arresT: a Pilot Study (EXACT)

Heart Arrest

Australia
Ambulance Victoria
Western Australian Ambulance Service; South Australian Ambulance Service

Completed

Rapid Infusion of Cold Normal Saline During CPR for Patients With Out-of-hospital Cardiac Arrest (RINSE)

Out-of-hospital Cardiac Arrest

Australia
The University of Western Australia

Unknown

High Density Lipoprotein (HDL) Functionality in Metabolic Syndrome

Metabolic Syndrome X

Australia

Clinical Trials on General Health Education in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bangladesh

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations